Ariad Pharmaceuticals announced it will cut 25 percent of its workforce

Things to consider when researching a regulatory affairs company, Essure is under the FDA microscope from complaints from patients, Bristol-Myers Squibb Co. to buy Padlock Therapeutics Inc., in a deal worth up to $600 million, Ariad Pharmaceuticals announced it will cut 25 percent of its workforce

Leave a Comment